Page 45 - Read Online
P. 45

Han et al. Cancer Drug Resist 2024;7:16  https://dx.doi.org/10.20517/cdr.2024.01  Page 7 of 25

               Table 1. Primers used for RT-qPCR analysis
                                             Primer sequence
                Gene
                          Forward (5’-3’)                         Reverse (5’-3’)
                MMP-2     GATACCCCTTTGACGGTAAGA                   CCTTCTCCCAAGGTCCATAGC
                MMP-9     GGGACGCAGACATCGTCATC                    TCGTCATCGTCGAAATGGGC
                PDK1      CGTACGGCAATGGCTTTATC                    AATCCCCTCCTGCAACTTCT
                RXRα      ATGGACACCAAACATTTCCTG                   GGGAGCTGATGACCGAGAAAG
                PPARα     TTCGCAATCCATCGGCGAG                     CCACAGGATAAGTCACCGAGG
                Bcl-2     GGTGGGGTCATGTGTGTGG                     CGGTTCAGGTACTCAGTCATCC
                β-actin   AAAGCGGCTGTTAGTCACTGG                   CGAGTCATTGCATACTGTCCAT
               RT-qPCR: Reverse transcription-quantitative polymerase chain reaction; MMP2/9: matrix metalloproteinase 2/9; PDK1: 3-phosphoinositide-
               dependent protein kinase 1.

               above drug treatment was repeated 6-8 times. The final drug concentration was stable and the drug-resistant
               cell line was obtained. The IC  values of drug-resistant cell lines were determined, and the resistance index
                                        50
               (RI) was calculated using the formula: RI = IC  of drug-resistant cell lines/IC  of parental cell lines. The RI
                                                                                50
                                                      50
               grades range from 1 to 5, indicating low drug resistance, 5 to 15, indicating moderate resistance, and above
               15, indicating high resistance. Triplicate experiments were performed independently.

               Inhibitory effect of isocuB on U251/TMZ resistant strains
               The primary physiological characteristics of tumor cells include proliferation, invasion, and migration. We
               evaluated the effect of isocuB on glioma cell proliferation using the CCK-8 assay. We initially used 0.25%
               trypsin to digest U251/TMZ-resistant strain cells at the logarithmic growth stage and subsequently diluted
               them to a seeding density of 7  × 10  cells/mL in 96-well plates. TMZ was then diluted to seven
                                                 4
               concentrations (10, 50, 100, 200, 500, 1,000, and 2,000  µmol/L). IsocuB was then diluted to seven
               concentrations (0.001, 0.01, 0.1, 0.5, 1, 5, and 25 µmol/L). These were added 24 h later. Finally, the CCK-8
               reagent was added at 24 h for absorbance detection at 450 nm using a microplate reader. Triplicate
               experiments were performed independently {Cell viability = [(OD Experiment group  - OD Blank )/(OD Control  group  -
               OD Blank )] × 100%}.

               Transfection of hsa-mir-1286a inhibitor increased the sensitivity of glioma U251 to TMZ
               We first used 0.25% trypsin to digest U251 cells at the logarithmic growth stage, and then diluted them to a
               seeding density of 7 × 10  cells/mL in 96-well plates. Human microRNA hsa-mir-1286a inhibitor was then
                                    4
               added to the 6-well plate at a concentration of 100 µmol/L, and RNA was extracted 24 h later. TMZ was
               then diluted to seven concentrations (10, 50, 100, 200, 500, 1,000, and 2,000 µmol/L) and added 24 h later.
               Finally, the CCK-8 reagent was added after 24 h for absorbance measurement at 450 nm using a microplate
               reader. Triplicate experiments were performed independently {Cell viability = [(OD Experiment group  - OD Blank )/
               (OD Control group  - OD Blank )] × 100%}.


               Transfection of hsa-miR-1286a mimic inhibited the sensitivity of glioma U251 to TMZ
               We initially used 0.25% trypsin to digest U251 cells at the logarithmic growth stage, and subsequently
               diluted them to a seeding density of 7 × 10  cells/mL in 96-well plates. A hsa-miR-1286a mimic was then
                                                    4
               added to the 6-well plate at a concentration of 100 µmol/L, and RNA was extracted 24 h later. TMZ was
               then diluted to seven concentrations (10, 50, 100, 200, 500, 1,000, and 2,000 µmol/L) and added 24 h later.
               Finally, the CCK-8 reagent was added after 24 h for absorbance measurement at 450 nm using a microplate
               reader. Triplicate experiments were performed independently {Cell viability = [(OD Experiment group  - OD Blank )/
               (OD Control group  - OD Blank )] × 100%}.
   40   41   42   43   44   45   46   47   48   49   50